SCHEMBL1735586

SCHEMBL1735586

Br/C=C\CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1521340 1.00
SCHEMBL5858068 1.00
Bicarbonate SCHEMBL4300889 0.83
Phosphoric Acid SCHEMBL16110763 0.80 ALDH1A1 (0.39)
SCHEMBL137154 0.75
SCHEMBL483199 0.75
SCHEMBL102759 0.75
SCHEMBL16933800 0.72
SCHEMBL8285979 0.70
SCHEMBL8431701 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2948437-B1 APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC (US) 2021-11-03 EP claimed
EP-2668176-B1 A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS SPHAERA PHARMA PTE LTD (SG) 2017-05-17 EP claimed
US-9556140-B2 Approach for synthesis of catechins SPHAERA PHARMA PVT. LTD. (IN) 2017-01-31 US claimed
US-9428482-B2 Process for synthesis of polyphenols SPHAERA PHARMA PTE. LTD. (SG) 2016-08-30 US claimed
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC. 2015-12-24 US claimed
US-20140031421-A1 NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS SPHAERA PHARMA PTE. LTD. (SG) 2014-01-30 US claimed
EP-1291353-B1 6-O-substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-06-01 EP claimed
EP-1291353-A1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 EP claimed
US-6028181-A 6-0-Substituted antibacterial erythromycin ketolides and methods of making ABBOTT LABORATORIES (US) 2000-02-22 US claimed
CN-111163763-B Method for inhibiting conversion of choline to Trimethylamine (TMA) 宝洁公司 2023-08-22 CN disclosed
US-11661403-B2 Oxadiazole compounds VIVACE THERAPEUTICS, INC. (US) 2023-05-30 US disclosed
EP-2948437-B1 APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC (US) 2021-11-03 EP disclosed
US-20210147408-A1 SMALL MOLECULE INHIBITORS OF GALECTIN-3 BRISTOL MYERS SQUIBB CO (US) 2021-05-20 US disclosed
EP-3522876-B1 METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) PROCTER & GAMBLE (US) 2021-02-24 EP disclosed
US-4668701-A Pesticides NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-05-26 US disclosed
EP-0046713-B1 FLUORINATED PENTENE DIAMINE DERIVATIVES MERRELL TORAUDE ET COMPAGNIE (FR) 1985-12-27 EP disclosed
US-4439619-A Fluorinated pentene diamine derivatives MERRELL TORAUDE ET COMPAGNIE (FR) 1984-03-27 US disclosed
US-4339460-A Pesticidal N-[4-(3'-bromoallyloxy)-phenyl]-N'-benzoyl ureas CIBA-GEIGY CORPORATION (US) 1982-07-13 US disclosed
EP-0046713-A1 Fluorinated pentene diamine derivatives MERRELL TORAUDE ET COMPAGNIE (FR) 1982-03-03 EP disclosed
US-3936462-A CNS DEPRESSANT, ANALGESIC STERLING DRUG INC. (US) 1976-02-03 US disclosed